BETH ISRAEL DEACONESS MEDICAL CENTER
- Country
- πΊπΈUnited States
- Ownership
- -
- Established
- 1896-01-01
- Employees
- -
- Market Cap
- -
- Website
- https://www.bidmc.org/
Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabRadiation: yttrium Y 90 ibritumomab tiuxetan
- First Posted Date
- 2005-05-04
- Last Posted Date
- 2017-11-21
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 12
- Registration Number
- NCT00110149
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈNorris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, United States
πΊπΈVermont Cancer Center at University of Vermont, Burlington, Vermont, United States
Boron Neutron Capture Therapy in Treating Patients With Stage III Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2004-09-02
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 15
- Registration Number
- NCT00002781
- Locations
- πΊπΈ
Boston University School of Medicine, Boston, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Combination Chemotherapy in Treating Patients With Previously Untreated, Newly Diagnosed Epithelial Tumors
- Conditions
- Endometrial CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2004-04-12
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00004082
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Interleukin-12 in Treating Women With Metastatic Breast Cancer Who Have Received High-Dose Chemotherapy and Peripheral Stem Cell Transplantation
- Conditions
- Breast Cancer
- First Posted Date
- 2004-03-31
- Last Posted Date
- 2013-09-17
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 35
- Registration Number
- NCT00003412
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Chemotherapy and Peripheral Stem Cell Transplantation Followed by Trastuzumab in Treating Women With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- First Posted Date
- 2004-02-12
- Last Posted Date
- 2018-05-16
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00006123
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈHackensack University Medical Center, Hackensack, New Jersey, United States
Y 90 Ibritumomab Tiuxetan &Rituximab Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: rituximabRadiation: yttrium Y 90 ibritumomab tiuxetan
- First Posted Date
- 2003-12-11
- Last Posted Date
- 2018-01-23
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 25
- Registration Number
- NCT00073957
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
πΊπΈFletcher Allen Health Care - Medical Center Campus, Burlington, Vermont, United States
Boron Neutron Capture Therapy in Treating Patients With Melanoma
- Conditions
- Melanoma (Skin)
- First Posted Date
- 2003-05-07
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00059800
- Locations
- πΊπΈ
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Topotecan in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
- Conditions
- Fallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity Cancer
- First Posted Date
- 2003-03-07
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Target Recruit Count
- 20
- Registration Number
- NCT00055614
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Boron Neutron Capture Therapy in Treating Patients With Glioblastoma Multiforme or Melanoma Metastatic to the Brain
- Conditions
- Melanoma (Skin)Brain and Central Nervous System TumorsMetastatic Cancer
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00039572
- Locations
- πΊπΈ
Massachusetts Institute of Technology, Cambridge, Massachusetts, United States
πΊπΈBeth Israel Deaconess Medical Center, Boston, Massachusetts, United States
Monoclonal Antibody Therapy in Treating Patients With Refractory Anaplastic Large Cell Lymphoma or Hodgkin's Lymphoma
- Conditions
- Lymphoma
- First Posted Date
- 2003-01-27
- Last Posted Date
- 2013-06-26
- Lead Sponsor
- Beth Israel Deaconess Medical Center
- Registration Number
- NCT00003741
- Locations
- πΊπΈ
Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States